<DOC>
	<DOCNO>NCT01528267</DOCNO>
	<brief_summary>The prupose study determine feasibility , effectiveness , safety inject blood airway cause lung volume reduction people severe emphysema .</brief_summary>
	<brief_title>Bronchoscopic Lung Volume Reduction Using Blood</brief_title>
	<detailed_description>This randomise , double blind , placebo control trial response patient treat blood LVR compare patient treat placebo ( control group ) . Analysis evaluate mean change lobar lung volume determine compute tomography ( CT ) scan 6 week two study arm base subject ' blind bronchoscopic intervention . Initial assessment comprise - Clinical evaluation - Full pulmonary function test ( PFTs ) - static dynamic lung volume gas transfer - SGRQ - Dyspnoea Score - CT scan Suitable patient randomise receive either autologous blood , normal saline inject target airway . Procedures patient carry conscious sedation and/or anaesthesia . After bronchoscopic examination airway , 100ml patient blood collect use two 50ml syrinx . A balloon catheter insert target segment 25 ml blood inject via balloon catheter . The balloon inflate maintain position 6 minute order minimise risk overspill blood area lung . The balloon catheter reposition next segment target lobe lung process repeat segment treat . It anticipate whole procedure last 45-60 minute , include balloon removal . The placebo arm involve identical protocol , except injection 30mls 0.9 % saline replace injection blood . 3 segment 'treated ' . The blood retrieve start procedure discard . A course antibiotic pulse corticosteroid procedure discretion investigator . Post-operative CXRs order clinical indication ( e.g . cough , fever , increase breathlessness ) . Reassessment occur 6 week . This undertaken blind assessment team knowledge study arm patient randomise , access initial procedure record . This remove expectation subjectivity assessment . Assessment consist follow : - Clinical evaluation - Full pulmonary function test ( PFTs ) - static dynamic lung volume gas transfer - SGRQ - Dyspnoea Score - Blinding questionnaire patient assessment team - CT scan After assessment complete patient un-blinded informed treatment group assign . Subjects make aware process expect irreversible . However , problem bronchoscopy ( example worsen hypoxia ) , procedure abandon soon safe . A log adverse serious adverse event patient keep part safety monitor trial . Those enter control arm study offer real procedure end study benefit apparent</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Age 1880 year Moderate severe airflow obstruction FEV1 &lt; 50 % Predicted Severe dyspnoea mMRC ≥2 Hyperinflation total lung capacity ( TLC ) ≥100 % predict , RV ≥150 % predict Optimum COPD treatment least 6 week No COPD exacerbation least 6 week Less 3 admission exacerbation precede 12 month Patient unable provide inform consent Total lung CO uptake ( TLCO ) &lt; 15 % predict FEV1 &lt; 15 % predict pO2 air &lt; 6.0kPa pCO2 air &gt; 8.0kPa Other major medical illness , e.g . lung cancer limit participation Clinically significant bronchiectasis Large bulla 1/3 hemithorax volume ( i.e . bullectomy would suitable ) CT scan Arrhythmia cardiovascular disease pose risk procedure Prednisolone dose great 10mg day Prior LVRS lobectomy Lung nodule require surgery Female childbearing age positive pregnancy test Subject participate research study investigational drug device prior 30 day Subject take clopidogrel , warfarin , anticoagulant unable abstain 5 day preprocedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Emphysema , lung volume reduction , autologous blood</keyword>
</DOC>